Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.
Showing 7641–7660 of 17,773 recalls
Direct Rx
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level per manufacturer
Par Pharmaceutical, Inc.
Presence of Particulate Matter; glass fragment observed in one vial of reconstituted product
Preferred Pharmaceuticals, Inc
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer